论文部分内容阅读
对 1 2 4例IGT者应用阿卡波糖进行为期 2 4周的干预。结果 :空腹血糖 (FBG)、餐后血糖 (PBG)、糖化血红蛋白 (HbAic)、果糖胺水平 (FMN)和体重指数 (BMI)均有显著下降 (P <0 0 0 1 )。血压 (BP)、胰岛素、C肽、肾功水平无差异性变化 (P <0 0 0 5 )。不良反应是消化道症状 ,与药物剂量有关。
A total of 124 cases of IGT application of acarbose for a period of 24 weeks of intervention. Results: Fasting plasma glucose (FBG), postprandial blood glucose (PBG), HbAic, fructosamine (FMN) and body mass index (BMI) were significantly decreased (P <0.01). Blood pressure (BP), insulin, C-peptide and renal function had no difference (P <0.05). Adverse reactions are gastrointestinal symptoms, and drug dose.